IMMUCELL CORP's ticker is ICCC and the CUSIP is 452525306. A total of 31 filers reported holding IMMUCELL CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $83,393 | +3.5% | 15,617 | -3.1% | 0.04% | +17.1% |
| Q2 2023 | $80,585 | +0.7% | 16,117 | +2.9% | 0.04% | -14.6% |
| Q1 2023 | $80,058 | -16.1% | 15,667 | +0.1% | 0.04% | -24.1% |
| Q4 2022 | $95,465 | -18.4% | 15,650 | 0.0% | 0.05% | -25.0% |
| Q3 2022 | $117,000 | -14.0% | 15,650 | 0.0% | 0.07% | -12.2% |
| Q2 2022 | $136,000 | -9.9% | 15,650 | 0.0% | 0.08% | +17.1% |
| Q1 2022 | $151,000 | +18.9% | 15,650 | -1.3% | 0.07% | +32.1% |
| Q4 2021 | $127,000 | – | 15,850 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Financial Services, Inc. | 23,776 | $89,000 | 0.03% |
| SHUFRO ROSE & CO LLC | 51,263 | $192,000 | 0.02% |
| Tower Research Capital LLC (TRC) | 254 | $1,000 | 0.00% |
| Creative Planning | 310 | $1,000 | 0.00% |
| Renaissance Technologies | 10,000 | $38,000 | 0.00% |
| UBS AG | 1,870 | $7,000 | 0.00% |
| US BANCORP \DE\ | 24 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 2,032 | $8,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1 | $0 | 0.00% |
| MORGAN STANLEY | 29,628 | $111,000 | 0.00% |